If the interim look succeeds, the share price will soar and the ATM will become a more effective form of capital.
But how long will it take to get to the peek? I don't personally think the trial will enrol quickly. If it takes 1.5 years to enrol half the patients (best case scenario in my VHO), it will take another 3 years to get to the OS peek.
IMO, it's unlikely that BP will risk big bucks on a partnership considering the irregular state of the bavi data. Risk management necessitates a more definitive proof before inking a costly deal. At this point, the data is, functionally, a black hole—there are huge biostatistical uncertainties.
Peregrine will have to fund the trial and the rest of its business through the peek at minimum.
I don't agree with your loan analysis. We wouldn't have needed the ATM if Fargo hadn't happened, we would have partnered. So terribly sad.
All above IMO